$ACHV
ACHIEVE LIFE SCIENCES, INC.

2015 Q2 Form 10-Q Financial Statement

#000156459015007261 Filed on August 13, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q2
Revenue $4.025M $4.930M
YoY Change -18.36% -22.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.070M $2.680M
YoY Change 14.55% 8.5%
% of Gross Profit
Research & Development $6.545M $9.883M
YoY Change -33.78% -25.48%
% of Gross Profit
Depreciation & Amortization $70.00K $50.00K
YoY Change 40.0% -16.67%
% of Gross Profit
Operating Expenses $6.545M $9.883M
YoY Change -33.78% -25.48%
Operating Profit
YoY Change
Interest Expense $10.00K $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$423.0K $615.0K
YoY Change -168.78% -36.99%
Pretax Income -$6.010M -$7.020M
YoY Change -14.39% -16.63%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$6.010M -$7.015M
YoY Change -14.33% -16.69%
Net Earnings / Revenue -149.32% -142.29%
Basic Earnings Per Share
Diluted Earnings Per Share -$601.0M -$702.0M
COMMON SHARES
Basic Shares Outstanding 14.75M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.20M $40.60M
YoY Change 48.28% -28.77%
Cash & Equivalents $37.00M $40.61M
Short-Term Investments $12.20M $0.00
Other Short-Term Assets $2.300M $2.300M
YoY Change 0.0% -34.29%
Inventory
Prepaid Expenses
Receivables $100.0K $4.951M
Other Receivables $100.0K $0.00
Total Short-Term Assets $62.70M $47.85M
YoY Change 31.03% -28.9%
LONG-TERM ASSETS
Property, Plant & Equipment $400.0K $354.0K
YoY Change 12.99% -29.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $1.274M
YoY Change -84.3% -15.07%
Total Long-Term Assets $700.0K $1.879M
YoY Change -62.75% -6.05%
TOTAL ASSETS
Total Short-Term Assets $62.70M $47.85M
Total Long-Term Assets $700.0K $1.879M
Total Assets $63.40M $49.73M
YoY Change 27.48% -28.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $300.0K $1.341M
YoY Change -77.63% 1241.0%
Accrued Expenses $12.70M $13.25M
YoY Change -4.14% 27.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $1.100M
YoY Change -90.91% 0.0%
Total Short-Term Liabilities $35.04M $20.17M
YoY Change 73.69% 58.83%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $3.100M
YoY Change -96.77% -20.51%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.0K $3.100M
YoY Change -96.77% -20.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.04M $20.17M
Total Long-Term Liabilities $100.0K $3.100M
Total Liabilities $35.17M $23.27M
YoY Change 51.14% 40.16%
SHAREHOLDERS EQUITY
Retained Earnings -$170.5M -$149.3M
YoY Change 14.19%
Common Stock $196.1M $173.2M
YoY Change 13.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $0.00 $26.47M
YoY Change
Total Liabilities & Shareholders Equity $63.36M $49.73M
YoY Change 27.39% -28.24%

Cashflow Statement

Concept 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$6.010M -$7.015M
YoY Change -14.33% -16.69%
Depreciation, Depletion And Amortization $70.00K $50.00K
YoY Change 40.0% -16.67%
Cash From Operating Activities $16.66M -$2.910M
YoY Change -672.51% -61.04%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$60.00K
YoY Change 0.0% -50.0%
Acquisitions
YoY Change
Other Investing Activities $2.910M $8.920M
YoY Change -67.38% 15.54%
Cash From Investing Activities $2.850M $8.860M
YoY Change -67.83% 16.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.210M 6.030M
YoY Change -46.77%
NET CHANGE
Cash From Operating Activities 16.66M -2.910M
Cash From Investing Activities 2.850M 8.860M
Cash From Financing Activities 3.210M 6.030M
Net Change In Cash 22.72M 11.98M
YoY Change 89.65% 9115.38%
FREE CASH FLOW
Cash From Operating Activities $16.66M -$2.910M
Capital Expenditures -$60.00K -$60.00K
Free Cash Flow $16.72M -$2.850M
YoY Change -686.67% -61.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Liabilities
Liabilities
35165000
CY2015Q2 ogxi Lease Termination Liability Current
LeaseTerminationLiabilityCurrent
1250000
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2967000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
35035000
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23484944
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
us-gaap Share Based Compensation
ShareBasedCompensation
1228000
us-gaap Share Based Compensation
ShareBasedCompensation
2016000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1333000
CY2015Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
54000
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1252000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
863000
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17778000
CY2015Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
130000
CY2015Q2 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
10478000
CY2014Q4 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
13462000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
236000
CY2014Q4 ogxi Lease Termination Liability Current
LeaseTerminationLiabilityCurrent
3250000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5433000
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
24000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
196067000
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170537000
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2637000
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
28191000
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63356000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5765000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26786000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3319000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14855338
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10512000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14987706
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23072773
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1202000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7016000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15653000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
CY2014Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-615000
us-gaap Investment Income Interest
InvestmentIncomeInterest
67000
us-gaap Costs And Expenses
CostsAndExpenses
32219000
us-gaap Investment Income Interest
InvestmentIncomeInterest
16000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1465000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6010000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-423000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3213000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
106000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-35000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-92000
CY2014Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6008000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
56000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
615000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-7015000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
us-gaap Net Income Loss
NetIncomeLoss
-10527000
us-gaap Depreciation
Depreciation
110000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-218000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3706000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26021000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40614000
us-gaap Net Income Loss
NetIncomeLoss
-15651000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
51000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24433734
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24467727
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6064000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
215000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1003000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
8012000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24845000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
265000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
67000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
6725000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
24563000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
20104000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14593000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3002000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
253538
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
49348
ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4025000
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
us-gaap Depreciation
Depreciation
116000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-37000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5527000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-842000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
230000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1909000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2984000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-81000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-724000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-61000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-194000
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-383000
ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-127000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
17778000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10216000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4604000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
ogxi Proceeds In Advance For Issuing Warrants
ProceedsInAdvanceForIssuingWarrants
3174000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2860000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3161000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
2025000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
us-gaap Stock Issued1
StockIssued1
254000
CY2015Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12185000
ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
456797
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17370
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1722846
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.87
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.59
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0181
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.81
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
712000
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1016000
CY2015Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2400000
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3700000
ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2015Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2967000
CY2015Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
60376000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
35000
CY2015Q2 us-gaap Cash
Cash
11036000
CY2015Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12189000
CY2015Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q2 ogxi Common Stock Sales Agreement Net Amount
CommonStockSalesAgreementNetAmount
14700000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1283419
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015Q1 ogxi Additional Contingent Liability Early Termination Of Lease Agreement
AdditionalContingentLiabilityEarlyTerminationOfLeaseAgreement
1300000
ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2015-09
CY2015Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
100000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
CY2014Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
700000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1400000
CY2015Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
ogxi Indemnification Expense
IndemnificationExpense
0

Files In Submission

Name View Source Status
0001564590-15-007261-index-headers.html Edgar Link pending
0001564590-15-007261-index.html Edgar Link pending
0001564590-15-007261.txt Edgar Link pending
0001564590-15-007261-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201508132008170083268.jpg Edgar Link pending
ogxi-10q_20150630.htm Edgar Link pending
ogxi-20150630.xml Edgar Link completed
ogxi-20150630.xsd Edgar Link pending
ogxi-20150630_cal.xml Edgar Link unprocessable
ogxi-20150630_def.xml Edgar Link unprocessable
ogxi-20150630_lab.xml Edgar Link unprocessable
ogxi-20150630_pre.xml Edgar Link unprocessable
ogxi-ex102_685.htm Edgar Link pending
ogxi-ex311_7.htm Edgar Link pending
ogxi-ex312_8.htm Edgar Link pending
ogxi-ex321_6.htm Edgar Link pending
ogxi-ex322_9.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending